Home / Coagulation Factor VIII / Czechia
CZ ATC B02BD02 · updated 2 Nov 2026
Coagulation Factor VIII shortage in Czechia
Is there a Coagulation Factor VIII shortage in Czechia?
Yes. As of 2 Nov 2026, 1 Coagulation Factor VIII product is reported short in Czechia, the first since 21 Sep 2026. The company estimate for the return is 30 Sep 2027. Main reason: commercial decision or withdrawal.
Also short in Italy, Spain, Austria, Belgium, Switzerland. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | ELOCTA 750IU 750IU INJ PSO LQF 1+1X3ML ISP+AD | Swedish Orphan Biovitrum AB (publ), Stockholm | 21 Sep 2026 | 30 Sep 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.